Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Oncolytics Bio (ONC.TO)

Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 92,489
  • Shares Outstanding, K 77,074
  • Annual Sales, $ 0 K
  • Annual Income, $ -27,752 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.91
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 10.21
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.36
  • Most Recent Earnings $-0.12 on 11/12/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.11
  • Number of Estimates 2
  • High Estimate -0.10
  • Low Estimate -0.12
  • Prior Year -0.05
  • Growth Rate Est. (year over year) -120.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.17 +1.71%
on 12/13/24
1.48 -19.59%
on 11/19/24
-0.28 (-19.05%)
since 11/13/24
3-Month
1.15 +3.48%
on 10/02/24
2.08 -42.79%
on 10/07/24
-0.11 (-8.46%)
since 09/13/24
52-Week
1.15 +3.48%
on 10/02/24
2.08 -42.79%
on 10/07/24
-0.55 (-31.61%)
since 12/13/23

Most Recent Stories

More News
Stocks in play: Oncolytics Biotech Inc

Announced that the Data Safety Monitoring Board (DSMB) has recommended continued enrollment in Cohort ...

ONC.TO : 1.19 (-0.83%)
Oncolytics Biotech® Reports Completion of Initial Safety Phase Enrollment for GOBLET Trial's New Pancreatic Cancer Cohort

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 0.8208 (-1.78%)
ONC.TO : 1.19 (-0.83%)
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend

/CNW/ -- USA News Group News Commentary – Despite death rates for some cancers being on the decline, there is a global surge in cancer cases among people under...

ONCY : 0.8208 (-1.78%)
CKPT : 3.67 (-3.42%)
RCUS : 16.65 (-2.97%)
BCTX : 0.6499 (-1.71%)
ONC.TO : 1.19 (-0.83%)
AKYA : 2.33 (-4.12%)
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Despite death rates for some cancers being on the decline, there is...

ONCY : 0.8208 (-1.78%)
CKPT : 3.67 (-3.42%)
RCUS : 16.65 (-2.97%)
BCTX : 0.6499 (-1.71%)
AKYA : 2.33 (-4.12%)
ONC.TO : 1.19 (-0.83%)
Biotech Companies’ Q3 Updates: Promising Cancer Treatments on the Horizon

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As many biotech companies within the oncology space begin to roll...

ONCY : 0.8208 (-1.78%)
IOVA : 7.71 (-3.14%)
SNDX : 13.54 (+0.52%)
ONC.TO : 1.19 (-0.83%)
IBRX : 2.86 (-5.92%)
SWTX : 38.06 (-1.63%)
Biotech Companies' Q3 Updates: Promising Cancer Treatments on the Horizon

/CNW/ -- USA News Group News Commentary – As many biotech companies within the oncology space begin to roll out their end-of-quarter results, the American...

ONCY : 0.8208 (-1.78%)
IOVA : 7.71 (-3.14%)
SNDX : 13.54 (+0.52%)
ONC.TO : 1.19 (-0.83%)
IBRX : 2.86 (-5.92%)
SWTX : 38.06 (-1.63%)
Stocks in play: Oncolytics Biotech Inc

Today announced third quarter financial results and operational highlights. Highlights include BRACELET-1 ...

ONC.TO : 1.19 (-0.83%)
Stocks in play: Oncolytics Biotech® Inc.

Announced third-quarter net loss for the third quarter of 2024 was $9.5 million, compared to a net loss ...

ONC.TO : 1.19 (-0.83%)
Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced third...

ONCY : 0.8208 (-1.78%)
ONC.TO : 1.19 (-0.83%)
Stocks in play: Oncolytics Biotech Inc

Announced it will host a conference call and webcast on Tuesday, November 12, 2024, at 8:30 a.m. ET ...

ONC.TO : 1.19 (-0.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the...

See More

Key Turning Points

3rd Resistance Point 1.28
2nd Resistance Point 1.25
1st Resistance Point 1.23
Last Price 1.19
1st Support Level 1.18
2nd Support Level 1.15
3rd Support Level 1.13

See More

52-Week High 2.08
Fibonacci 61.8% 1.72
Fibonacci 50% 1.62
Fibonacci 38.2% 1.51
Last Price 1.19
52-Week Low 1.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar